
Transactions: Sweden
Filter


Secondary placing of 965,000 shares in Meda AB (SE) — SEK 300 million

Initial public offering of Orexo (SE) — SEK 333 million

Rights issue in Oasmia Pharmaceutical (SE) — SEK 123 million

New share issue in Fastighets AB Klövern (SE) — SEK 260 million

Secondary placing of 19.5 million shares in Fabege (SE) — SEK 663 million

Secondary placing of 7 million shares in Intrum Justitia (SE) — EUR 41 million

Rights issue in Active Biotech (SE) — SEK 255 million

Option program in Biovitrum (SE)

Acquisition of Attendo AB (SE) by Bridgepoint (UK) — SEK 2.2 billion

Public offer for Biacore International (SE) by GE Healthcare (US) — SEK 3.2 billion
